Trial Design Webinars
-
Navigating Early Phase CNS-Active Drug Development
2/14/2023
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating the risk/benefit profile.
-
What Therapeutic Areas Have Walgreens And CVS Health Already Begun To Serve?
2/10/2023
Pharmacy sites might be well positioned within their communities to serve a wide swath of patients. But what about the scope of their therapeutic areas of study? Walgreens Head of Decentralized Clinical Trials John Campbell and CVS Health Senior VP of Clinical Trial Services Tony Clapsis share each pharmacy’s current breadth of coverage.
-
Why Post-Study Patient Engagement Is Crucial To Patient Experience And Future Trial Success
2/10/2023
Nobody likes being ghosted, especially clinical trial patients giving their time and bodies to improve health outcomes for themselves and others. Walgreens Head of Decentralized Clinical Trials John Campbell discusses the importance of keeping participants in-the-know and feeling appreciated.
-
Are We Doing Enough To Reduce Participant Burden In Clinical Trials?
2/10/2023
The short answer: No. Asked whether industry is doing enough to accommodate patients enrolled in clinical trials, Walgreens Head of Decentralized Clinical Trials John Campbell and CVS Health Senior VP of Clinical Trial Services Tony Clapsis discuss the current state of patient burden and opportunities for improvement.
-
How Do Most Patients Learn About Clinical Trials? Not Their PCP
2/10/2023
Patient referrals to clinical trials can happen in many ways. But the most common way is not through their primary care physician. Tony Clapsis, senior vice president of clinical trial services at CVS Health, and John Campbell, head of decentralized clinical trials at Walgreens, discuss patients’ first touchpoints and how to reach them better and earlier for higher enrollment.
-
CVS Health, Walgreens Leverage Multi-Channel Outreach To Raise Recruitment
2/10/2023
It’s not a one-size-fits-all approach when it comes to raising awareness of clinical trials. Tony Clapsis, senior vice president of clinical trial services at CVS Health, and John Campbell, head of decentralized clinical trials at Walgreens, talk about their multipronged approach to reaching potential trial participants.
-
Improving Accessibility To Increase Patient Participation With CVS Health
2/10/2023
Surprisingly, interest in participating in clinical trials is nearly equal across races and ethnicities, according to Tony Clapsis, citing data from CVS Health. The problem? Taking that initial interest and evolving it into participation. Clapsis shares CVS’s plans for improving accessibility for all.
-
Walgreens Sees “Optionality,” Or Flexible Participation, As The Way Forward With Hybrid Trials
2/10/2023
Walgreens Head of Decentralized Clinical Trials John Campbell believes clinical trials will one day allow patient to choose when and where they will participate in a clinical trial. Campbell contends true patient centricity would allow patients to pick whether they’re seen at home, at a site, at a pharmacy, or any combination of locations.
-
How CVS Health Intends To Overcome Patient Enrollment And Retention Hurdles
2/10/2023
Tony Clapsis, senior vice president of clinical trial services, shares how CVS Health aims to overcome the challenge of patient enrollment and retention by using CVS sites as well as home research nursing, among other approaches, to meet patient accessibility needs.
-
Strategic Considerations For A Successful CNS Clinical Development Pathway
2/7/2023
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, discusses tactics for a successful clinical development pathway for CNS-active drugs.